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ABSTRACT: There is great interest in fluorogenic com-
pounds that tag biomolecules within cells. Biarsenicals are
fluorogenic compounds that become fluorescent upon binding
four proximal Cys thiols, a tetracysteine (Cys4) motif. This
work details interactions between the biarsenical AsCy3 and
Cys4 peptides. Maximal affinity was observed when two Cys-
Cys pairs were separated by at least 8 amino acids; the highest
affinity ligand bound in the nanomolar concentration range
(Kapp = 43 nM) and with a significant (3.2-fold) fluorescence
enhancement.
There is great interest in the identification of fluorogeniccompounds that tag biomolecules within cells. Molecules
with these properties, especially those that are bright, specific,
and nontoxic, can often extract high-resolution information
from within a complex, heterogeneous environment.1 When the
biomolecule is a protein, fluorogenic compounds can define
intracellular location, monitor protein−protein interactions,
discriminate conformations, and quantify protein activity.
Biarsenical dyes,2 exemplified by FlAsH3 and ReAsH,4
represent one such class of fluorogenic compound. These
compounds are distinguished by a fluorescence enhancement
that occurs upon binding to proteins containing four proximal
Cys thiols, a tetracysteine (Cys4) motif. Over the past dozen
years, fluorogenic biarsenicals have been used to label and
visualize β-tubulin,5 monitor amyloid formation,6 localize
viruses,7 probe transmembrane α-helix interactions and
orientations,8 and evaluate conformational changes in the β2-
9
and α2A-arenergic receptors,
10 among other applications.11
These important discoveries notwithstanding, the application
of FlAsH and ReAsH to discover new biology (especially within
the cell) is limited by strong background labeling and relatively
weak fluorescence.2,4 Background labeling results from the
interaction of FlAsH and ReAsH with nonspecific thiols as well
as membranes and hydrophobic protein pockets.2 Even with an
improved binding sequence,12 ReAsH is still less bright than
common fluorophores such as Alexafluor-488 and BODIPY FL.
Moreover, despite the differences in their emission maxima
(528 and 608 nm, respectively) the similarity of the FlAsH and
ReAsH structures prohibits their use in simultaneous two-color
labeling experiments.4
Recently we applied the biarsenical ReAsH in a bipartite
mode13 along with total internal reflectance microscopy (TIR-
FM) to detect, characterize, and differentiate ligand-induced
conformational changes within the epidermal growth factor
receptor (EGFR) on the mammalian cell surface.13,14 Through
the design of EGFR variants with Cys-Cys pairs within the
cytosolic juxtamembrane (JM) segment, we discovered that the
binding of the growth factor EGF induced the formation of an
anti-parallel coiled coil within the JM that was functionally
linked to kinase activation. Other growth factors, most notably
TGF-α, induced a different structure.13,14 Our ability to probe
and differentiate structures within the juxtamembrane segment
would be greatly enhanced by an alternative to FlAsH and
ReAsH, especially one that was bright and photostable and
could detect and report on alternative Cys4 motifs.
One molecule with some potential in this regard, AsCy3
(Figure 1A), was reported in 2007.15 In AsCy3 the biarsenical
motif is displayed on a Cy3 scaffold and was reported to bind
the alternative Cys4 motif Cys-Cys-Lys-Ala-Glu-Ala-Ala-Cys-
Cys with a brightness comparable to that of ReAsH (5.0 × 104
M−1 cm−1)4,10 and significantly greater (>30-fold) photo-
stability.15 Since 2007, AsCy3 has been transformed into a
super-resolution probe16 and a membrane-permeable dye via
substitution of the anionic sulfonate side chains for methyl
esters,17 and the monoarsenic variant has explored dithiol
oxidation in bacteria.18 Here we report that the initially
described Cys4 motif binds AsCy3 with only modest affinity
and fluorescent enhancement, but that higher affinity (100-
fold) and brightness (>3-fold) is seen with the expanded Cys4
motif Cys-Cys-Lys-Ala-Glu-Ala-Ala-Lys-Ala-Glu-Ala-Ala-Lys-
Cys-Cys. We hope that this information will aid researchers
as they apply AsCy3 to characterize protein interactions on the
cell surface and ultimately within the cytosol.
AsCy3 was synthesized following a modified procedure
(Scheme S1 in Supporting Information), and its identity was
confirmed with 1H and 13C NMR and high-resolution mass
spectrometry. When dissolved at 10 μM in 50 mM HEPES (pH
7.5) containing 10% DMSO, the parent Cy3 displayed an
absorbance maximum at 546 nm (ε546 = 126,000 M
−1 cm−1)
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and a emission maximum at 557 nm (Figure S1 in Supporting
Information). These values compare well with those in
methanol, where an absorbance maximum at 549 nm (ε549 =
120,000 M−1 cm−1) was reported.19 Both the absorbance and
emission maxima of AsCy3 are red-shifted relative to Cy3;
under identical conditions AsCy3 exhibited maximal absorb-
ance at 564 nm (ε564 = 103,000 M
−1 cm−1) and maximal
emission at 575 nm (Figure S1 in Supporting Information).
These values differ slightly from those reported: λmax = 560 nm
(absorbance, ε560 = 180,000 M
−1 cm−1); λmax = 568 nm
(emission).
The initial AsCy3 report described interactions with Cy3Tag,
a 34-aa peptide containing two Cys-Cys motifs separated by the
sequence Lys-Ala-Glu-Ala-Ala (Figure 1A). As reported, the
complex formed with an equilibrium dissociation constant
(Kapp) of 80 ± 10 nM, calculated on the basis of CyTag-
dependent changes in fluorescence intensity at 576 nm. We
repeated the titration of AsCy3 with CyTag, monitoring
changes in both fluorescence polarization (FP, which measures
binding directly) and fluorescence intensity (FI, which does
not). Experiments were performed initially under the
conditions reported: HEPES buffer containing 10% DMSO,
140 mM KCl, 1 mM TCEP, 100 μM EDT, and 1 mM BME.
No interaction between AsCy3 and Cy3Tag was observed
under these conditions whether the association was monitored
by changes in FI or FP at Cy3Tag concentrations as high as 15
μM (Figure 1B). However, in a buffer lacking the competitive
inhibitors EDT and BME, concentration-dependent changes in
both FP and FI were observed. In each case, the data fit a
simple 1:1 equilibrium-binding isotherm to provide Kapp values
of 970 ± 140 nM (FI) and 2.4 ± 0.6 μM (FP). These values are
at least an order of magnitude higher than those reported by
Cao et al.15 and were obtained only in the absence of thiol
competitors. Competition of the AsCy3·CyTag complex with
EDT yielded an inhibition constant (Ki) of 5.6 ± 0.9 μM, a
value only slightly higher than the Kapp values determined for
the CyTag complex, providing additional evidence for a low-
affinity AsCy3·CyTag interaction. Although cyanine dyes such
as AsCy3 can aggregate,20 our experimental setup minimizes
the effect of [AsCy3] on the calculated Kapp (see Supporting
Information).
The interactions between AsCy3 and CyTag were also
studied by characterizing the changes in the fluorescence
spectrum of AsCy3 in the presence of Cy3Tag (Figure S1C in
Supporting Information). Upon incubation of 100 nM AsCy3
(in 50 mM HEPES pH 7.5, 140 mM KCl, and 1 mM TCEP)
with 10 μM Cy3Tag, the emission maximum was maintained at
575 nm as expected,15 but fluorescence emission was increased
by only 2.5-fold, significantly less than the reported 6-fold
increase under similar conditions.15
These results prompted us to evaluate the structure of AsCy3
and its complex with CyTag. The ground state geometry of
AsCy3 bound to two ethanedithiol (EDT) ligands (calculated
using Gaussian 0921 and the internal molecular mechanics UFF
package) was characterized by an interatomic As−As distance
of 15.83 Å, a value longer than that between the α-carbons of
residues i and i + 7 on a canonical α-helix (10.8 Å), the
proposed target site for AsCy3.15 Calculation of the ground
state geometry of AsCy3 bound to Cys-Cys-Lys-Ala-Glu-Ala-
Ala-Cys-Cys suggested a compressed interatomic As−As
distance (13.44 Å) and a non-α-helical peptide backbone
(Figure 1D). Furthermore, in the calculated complex, AsCy3
was nonplanar, with a > 100° angle between the normal vectors
to the two indole ring planes (Figure S2 in Supporting
Information). Cy3 fluorophores demand a planar, conjugated π
system to achieve significant quantum yields.22 These
calculations imply a mismatch between the structure of
AsCy3 and the most favorable disposition(s) of Cys-Cys
ligands on CyTag. They also suggest two factors that could
contribute to the low AsCy3·CyTag affinity: (1) interaction of
AsCy3 with only one Cys-Cys motif (not two) and (2) strain
energy associated with forming the Cys4-coordinate complex.
More importantly, the calculations suggest that target sites with
longer intervening sequences would better match the AsCy3
structure and permit the formation of a more planar, higher-
affinity, and more fluorogenic complex.
To better explore the AsCy3·CyTag binding mode, we
synthesized a pair of CyTag variants in which one (TagΔ2) or
both (TagΔ4) Cys-Cys motifs were replaced by Ala-Ala (Figure
2A). The interactions of TagΔ2 and TagΔ4 with AsCy3 were
evaluated by monitoring changes in both fluorescence intensity
(Figure 2B) and fluorescence polarization (Figure 2C) as a
function of peptide concentration. Only TagΔ2 showed
evidence of an interaction with AsCy3 (Figure 2B). As was
true for the CyTag interaction, the data could be fit to a 1:1
binding isotherm, yielding a Kapp value of 960 ± 150 nM based
on fluorescence intensity changes and Kapp = 410 ± 92 nM
based on changes in fluorescence polarization. These Kapp
values equal or exceed those determined for Cy3Tag itself,
depending on the method (FI, 970 ± 140 nM; FP, 2.3 ± 0.6
Figure 1. AsCy3 and its interactions with Cy3Tag. (A) Sequence of
Cy3Tag (left) and structure of AsCy3 (right). (B) Plots illustrating the
changes in FI (left) and FP (right) of 0.1 μM AsCy3 after incubation
with the [Cy3Tag] indicated in the presence (closed) and absence
(open) of 100 μM EDT and 1 mM BME. (C) Competition between
10 μM CyTag and [EDT] for 0.1 μM AsCy3, measured by changes in
FI. Errors show standard error. (D) Minimized structure (Gaussian) of
the hypothetical complex between AsCy3 and Cy3Tag.
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μM). The observation that AsCy3 interacts comparably with
peptides containing one or two Cys-Cys motifs suggests that
only one Cys-Cys pair in the Cy3Tag sequence contributes to
complex stability.18 Indeed, the change in AsCy3 fluorescence
emission (100 nM) in the presence of TagΔ2 (10 μM) is >60%
of the enhancement observed with CyTag. This observation
indicates that the second Cys-Cys pair contributes minimally, if
at all, to AsCy3 fluorogenicity, and the dye may only be
partially bound to all four cysteines (Figure S1C in Supporting
Information).
Next, we synthesized a second set of potential AsCy3 ligands
containing progressively longer intervening sequences and
evaluated their interactions with AsCy3 using fluorescence
intensity and polarization assays (Figure 3). These potential
AsCy3 ligands contained from 6 to 13 amino acids interposed
between the two Cys-Cys motifs and were largely unstructured
at 30 μM in the absence of AsCy3, as judged by circular
dichroism (CD) spectroscopy (5 mM phosphate (pH 7.5), 140
mM KCl, and 5 mM DTT) (Figure S3 in Supporting
Information). All of the second-generation peptides evaluated
formed complexes with AsCy3, exhibiting Kapp values between
49 nM and 1.3 μM in the absence of EDT and BME. With one
exception (Tag+2), the values determined using FI and FP
agreed to within their 95% confidence intervals (Table S1 in
Supporting Information). Notably, the fitted value of Kapp
decreased as the number of residues between the two Cys-
Cys motifs increased from 5 to 9, with the largest increase
between Tag+3 and Tag+4 (Figure S4 in Supporting
Information). The highest affinity ligand was Tag+6, whose
AsCy3 complex was characterized by a Kapp value of 94 ± 16
nM (FI); Kapp = 49 ± 13 nM by fluorescence polarization.
Titration of AsCy3 (100 nM) and Tag+6 (30 uM) with
between 5 nM and 10 μM EDT led to a systematic decrease in
fluorescence emission at 580 nm. This decrease could be fit to
yield an inhibition constant (Ki) of 9.3 ± 4.6 μM (Figure S5 in
Supporting Information), in agreement with the value
determined on the basis of competition with CyTag (Ki =
5.6 ± 0.9 μM). Thus, Tag+6 binds AsCy3 more than 100 times
more favorably than EDT or CyTag.
A final set of experiments was performed to provide
additional resolution of the binding mode. Substitution of
one Cys-Cys motif within Tag+6 to generate Tag+6Δ2 led to a
50-fold loss in equilibrium binding affinity, in contrast to the
minimal changes observed upon removal of a single Cys-Cys
motif from CyTag. The Tag+6Δ2·AsCy3 complex is
characterized by a Kapp value of 1.4 ± 0.36 μM by FP (FI,
860 ± 160 nM) (Figure 4), values very similar to those of
Cy3Tag itself, providing additional evidence that the Cy3Tag
interacts minimally with the second Cys-Cys motif in CyTag.
Incubation of Tag+6 with AsCy3 led to an overall 3.2-fold
increase in fluorescence, compared to only a 1.5-fold increase in
the case of Tag+6Δ2 (Figure S1C in Supporting Information).
In summary, we describe a detailed characterization of the
interactions between AsCy315 and various cysteine-rich
peptides. Maximal affinity was observed with Cys4 sequences
in which the two Cys-Cys pairs were separated by at least 8
amino acids; the highest affinity ligand was Tag+6, whose
complex with AsCy3 assembled in the nanomolar concen-
tration range (Kapp = 43 nM) and was characterized by a
significant (3.2-fold) fluorescence enhancement. We hope that
this information will aid other researchers as they apply AsCy3
to characterize protein interactions on the cell surface or
ultimately within the cytosol.
Figure 2. Interactions of AsCy3 with Cy3Tag and variants. (A)
Sequence of Cy3Tag, TagΔ2, and TagΔ4 with Kapp values determined
by FP. (B) Plot of the FI of 100 nM AsCy3 after incubation with the
Cy3Tag, TagΔ2, and TagΔ4. (C) Plot of the FP under identical
conditions. Error bars show standard error.
Figure 3. Interactions of AsCy3 with Tag+n sequences. (A) Sequences
of potential AsCy3 ligands and Kapp values determined by FP. (B) Plot
illustrating relationship between Kapp and the number of amino acids
separating the Cys-Cys motifs (n).
Figure 4. Interactions of AsCy3 with Tag+6 and Tag+6Δ2. (A)
Sequences of Tag+6 and Tag+6Δ2 with Kapp values measured by FP.
(B) Plot of the FI of 100 nM AsCy3 after incubation with the
indicated [Tag+6] and [Tag+6Δ2]. (C) Plot of the FP under identical
conditions. Error bars represent the standard error.
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